Belluscura PLC Director/PDMR Shareholding
19 Julio 2024 - 4:36AM
RNS Regulatory News
RNS Number : 0219X
Belluscura PLC
19 July 2024
19 July 2024
BELLUSCURA PLC
("Belluscura" or the
"Company")
PDMR
Award of Options
Belluscura plc (AIM: BELL), a
leading medical device developer focused on lightweight and
portable oxygen enrichment technology, announces
that the Company has today granted unapproved
share options ("Options") of 4.0 million ordinary shares of 1 penny each in the Company ("Ordinary
Shares") to Simon Neicheril, Chief Financial
Officer.
The Options have been awarded upon
the recommendation of the Company's Remuneration
Committee.
The Options have an exercise price
of 14.5 pence per share (being the closing mid-market price of the
Ordinary Shares on 18 July 2024) and will expire 10 years from the
date of grant.
The Options are subject to the
following performance criteria; 2.0 million Options will vest when
the price of the Ordinary Shares reaches 20p. The further 2.0
million Options will vest when the price of the Ordinary Shares
reaches 25p. Each Option is exercisable into one Ordinary
Share.
Upon a change in control of the
Company, or an Offer for the Company's entire Share Capital, or
termination of Mr. Neicheril's employment contract as a good
leaver, all remaining unvested Options will vest
immediately.
For further information please
contact:
|
Belluscura plc
|
Tel: +44
(0)20 3128 8100
|
|
Adam Reynolds, Chairman
|
|
|
Robert Rauker, Chief Executive
Officer
|
|
|
|
|
|
|
|
|
SPARK Advisory Partners
Limited - Nominated Adviser
|
Tel: +44
(0)20 3368 3550
|
|
Neil Baldwin / Jade
Bayat
|
|
|
|
|
|
|
|
|
Dowgate Capital Limited -
Broker
|
Tel: +44
(0)20 3903 7715
|
|
Russell Cook / Nicholas
Chambers
|
|
|
|
|
|
|
|
|
MHP Group - Financial PR &
Investor Relations
|
Tel: +44
(0)20 3128 8100
|
|
Katie Hunt / Matthew
Taylor
|
email: Belluscura@mhpgroup.com
|
|
|
|
About Belluscura plc
(https://belluscura.com/)
Belluscura is a UK medical device
company focused on developing oxygen enrichment technology spanning
broad industries and therapies. Our innovative oxygen technologies
are designed with a global purpose: to create improved health and
economic outcomes for the patients, healthcare providers and
insurance organisations.
Notification and
public disclosure of transactions by persons discharging managerial
responsibilities ("PDMRs") and persons closely associated ("PCA")
with them.
|
1
|
Details of the
person discharging managerial responsibilities / person closely
associated
|
|
a)
|
Name
|
Simon Neicheril
|
|
2
|
Reason for
notification
|
|
a)
|
Position / status
|
Chief Financial Officer
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
3
|
Details of the
issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
|
a)
|
Name
|
Belluscura plc
|
|
b)
|
LEI
|
213800BRJQZE56XBPW94
|
|
4
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary shares of £0.01 each in Belluscura plc
ISIN: GB00BD3B8Z11
|
|
b)
|
Nature of the transaction
|
Grant of Options over Ordinary shares of £0.01
each
|
|
c)
|
Price(s) and volumes(s)
|
|
Price(s)
|
Volumes(s)
|
|
14.5p
|
4,000,000
|
|
|
d)
|
Aggregated information
|
n/a
|
|
e)
|
Date of the transaction
|
19 July 2024
|
|
f)
|
Place of the transaction
|
Outside a Trading Venue
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHRPMTTMTMBTLI
Belluscura (LSE:BELL)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Belluscura (LSE:BELL)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
